TC BioPharm (Holdings) PLC (TCBP)
1.46
-0.02
(-1.35%)
USD |
NASDAQ |
May 02, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | -5.258M |
September 30, 2021 | -9.690M |
Date | Value |
---|---|
December 31, 2020 | -1.743M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-9.690M
Minimum
Sep 2021
-1.743M
Maximum
Dec 2020
-5.563M
Average
-5.258M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | -47.92M |
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | -9.507M |
Autolus Therapeutics PLC | -77.17M |
Mereo BioPharma Group PLC | -- |
Net Income (Quarterly) Related Metrics
Enterprise Value | 1.592M |
Earnings Yield | -346.3% |
Normalized Earnings Yield | -3563.42 |